Philip Inskeep received a BS degree from Virginia Polytechnic Institute and State University and a PhD degree from the Pennsylavania State University, both in biochemistry. He was a post-doctoral fellow at Vanderbilt University before starting his career in human and veterinary ADME science at Pfizer. He is the author of over 30 research papers and 2 invited reviews spanning pharmacokinetics, clinical pharmacology, pre-clinical ADME, and other areas in biochemistry.
Philip has extensive experience in drug discovery and development including research, document management, regulatory interactions and filings, and business development. He provides analysis and/or assessment of pharmacokinetic and drug metabolism data from pre-clinical or clinical studies for both human and veterinary medicines.